Quick Answer: A single chemotherapy infusion in 2026 costs between $2,000 and $15,000 total, depending on the drug and regimen. The administration fee alone (CPT 96413) runs $183 to $536 at most hospitals. The drug charge, billed through HCPCS J-codes, is usually the biggest line item and the most error-prone part of your bill.
If you recently received a hospital bill after chemotherapy and the numbers look overwhelming, you are not alone. Oncology billing is one of the most complex areas in healthcare, and roughly 30% of all medical bills contain errors. Chemo bills are especially vulnerable because they combine multiple CPT administration codes, specialty drug J-codes, facility fees, and infusion supplies, all billed separately and all subject to coding mistakes.
This guide breaks down exactly what each code means, what hospitals are allowed to charge in 2026, and how to check whether the numbers on your bill are accurate. You can also upload your bill directly to the CoveredUSA Bill Analyzer to flag line items that exceed standard Medicare benchmarks.
What Is CPT 96413?
CPT 96413 is the procedure code for the first hour of intravenous (IV) chemotherapy administration. It covers the clinical labor involved in setting up the infusion, monitoring the patient, and managing the IV line, not the drug itself.
According to hospital price transparency data compiled by cms.gov, the 2026 range for CPT 96413 looks like this:
| Payer Type | Typical Rate (2026) |
|---|
| Medicare Physician Fee Schedule | ~$133 |
| Cash / self-pay (median) | $183 |
| Commercial insurance (median) | $358 to $536 |
| Hospital chargemaster (list price) | $500 to $2,500+ |
The gap between the Medicare rate ($133) and what hospitals charge commercial payers ($536 median) is real and legal. The gap between the chargemaster price and what most people actually pay is where billing errors get hidden.
Add-On Administration Codes: 96415 and 96417
CPT 96413 is almost never the only administration code on a chemo bill. Most infusion sessions run longer than one hour, and many regimens combine multiple drugs. Two add-on codes follow 96413:
CPT 96415: Each additional hour of infusion
Billed once for each full additional hour beyond the first. A three-hour infusion would show 96413 + two units of 96415.
- Typical commercial rate: $55 to $75 per additional hour
- Never billed without 96413
- Requires documented start and stop times
CPT 96417: Each additional sequential drug
When a second chemotherapy drug is administered after the first one finishes (sequential infusion), 96417 captures that. It is not used when two drugs run simultaneously through the same IV line.
- Typical commercial rate: $130 to $170 per sequential drug
- Each new chemotherapy substance in the same session gets its own 96417
Common billing errors on these codes
- 96415 billed for partial hours (the code requires a full additional hour, not 30 minutes)
- 96417 billed for concurrent infusions (drugs running simultaneously do not qualify)
- Both 96413 and 96417 billed as "initial" codes in the same session (only one 96413 per session)
J-Codes: Where the Real Money Is
The administration codes above cover the nurse's time and the infusion setup. The drug itself is billed separately using HCPCS J-codes. These are five-character codes beginning with "J" that identify specific injectable drugs, their formulation, and the billable unit.
For chemotherapy drugs, J-codes fall in the J9000 to J9999 range. Here are the most commonly billed in 2026:
| Drug Name | J-Code | Billable Unit | Approximate Medicare Rate (2026) |
|---|
| Paclitaxel (Taxol) | J9267 | 1 mg | ~$0.16/mg |
| Paclitaxel protein-bound (Abraxane) | J9264 | 1 mg | ~$6.72/mg |
| Carboplatin | J9045 | 50 mg | ~$2.24/50mg |
| Oxaliplatin | J9263 | 0.5 mg | ~$0.86/0.5mg |
| Docetaxel | J9171 | 1 mg | ~$0.34/mg |
| Bevacizumab (Avastin) | J9035 | 10 mg | ~$67/10mg |
| Pembrolizumab (Keytruda) | J9271 | 1 mg | ~$97/mg |
Sources: CMS Medicare Coverage Database, PayerPrice 2026 fee schedules
Medicare pays for Part B chemotherapy drugs at Average Sales Price (ASP) plus 6%. Hospitals and outpatient infusion centers bill the drug at that rate when treating Medicare patients. Commercial payers negotiate their own rates, which are often 2x to 4x the Medicare rate. Uninsured patients are typically billed chargemaster prices, which can be 10x or more above Medicare.
How unit errors inflate your bill
Each J-code has a specific billable unit. Billing 100 units when the patient received 50 doubles the drug charge instantly. This is one of the most common errors in oncology billing, and it is easy to miss because the dose in milligrams rarely appears clearly on the summary EOB.
For example: A patient receiving 175 mg/m2 of paclitaxel for a body surface area of 1.9 m2 would receive approximately 332 mg. The hospital should bill 332 units of J9267. Billing 400 units, a rounding-up error or a transcription mistake, would inflate the charge by about 20%.
What a Typical Chemo Session Costs in 2026
A complete chemo infusion visit is not one line item. It is a stack of charges:
| Charge Component | Typical Range (2026) |
|---|
| Facility fee (hospital outpatient) | $500 to $3,000 |
| CPT 96413 (first-hour infusion admin) | $183 to $536 |
| CPT 96415 x hours (each add'l hour) | $55 to $75 per hour |
| Drug charge (J-code, most regimens) | $1,000 to $12,000+ |
| IV supplies and prep fees | $50 to $300 |
| Pre-medication drugs (anti-nausea, etc.) | $50 to $500 |
| Estimated total per session | $2,000 to $15,000 |
With insurance, your out-of-pocket per session usually runs $25 to $100 copay plus 20% coinsurance until you hit your deductible. Most patients facing chemotherapy hit their annual out-of-pocket maximum ($10,600 for 2026 ACA plans) early in their treatment year.
Without insurance, the average cost of a single chemotherapy session in the U.S. is approximately $10,000, according to cost data from Medical News Today and CancerCare Financial.
How Hospitals Get Away With Charging So Much
Hospital chargemaster prices for chemotherapy are set internally and bear little relationship to what any payer actually pays. The chargemaster is the starting point for negotiation. Insurers negotiate down to their contracted rate. Medicare pays its fixed rate. Uninsured patients, who have no negotiating power, are billed chargemaster prices.
This system is why the same Abraxane dose costs $800 for a Medicare patient and $8,000 for an uninsured one at the same hospital.
The No Surprises Act (2022) and CMS hospital price transparency rules require hospitals to publish their payer-specific rates, but compliance is inconsistent. As of 2026, the CMS has fined hospitals for failing to comply, but millions of bills are still generated without patients knowing the contracted rate beforehand.
Common Chemotherapy Billing Errors to Look For
Oncology billing specialists at PatientRightsAdvocate.org and Medical Bill Rescue identify several patterns that appear repeatedly in chemo bills:
- Duplicate charges: Same drug J-code billed twice in the same session
- Incorrect units: Drug billed in wrong quantity relative to documented dose
- Wrong code level: Administration code upcoded (e.g., 96417 billed instead of a less expensive concurrent code)
- Missing wastage documentation: Drugs billed that were prepared but not administered require a modifier; without it the charge may still appear
- Facility fee plus professional fee with no modifier: Both the hospital facility charge and the physician's charge should not both show full amounts without appropriate coordination
- Incorrect diagnosis code: A mismatched ICD-10 diagnosis code can cause the drug or administration code to be denied and rebilled at a higher rate
Near 30% of oncology claims face initial denial, and 73% of patients who challenged their bill got a correction, according to a 2024 JAMA Health Forum study.
How the CoveredUSA Bill Analyzer Can Help
Reading a chemo EOB requires knowing what ASP + 6% means for your specific drug, recognizing unit billing conventions, and understanding which CPT codes are allowed together. Most patients have none of this context and no way to check it.
The CoveredUSA Bill Analyzer compares each line on your bill to the current Medicare benchmark for that specific procedure and drug code. Upload your itemized hospital statement or EOB, and the analyzer flags line items that exceed the Medicare rate by more than the typical commercial markup range, a signal that a coding error or overcharge may be present.
Upload your hospital bill to the free CoveredUSA Bill Analyzer to find errors, overcharges, and charity care options in 30 seconds.
How to Appeal a Chemotherapy Bill
If you believe your chemo bill contains an error, here are the steps to follow in 2026:
- Request an itemized bill: Every patient has a federally protected right to an itemized statement. Call the hospital billing department and ask for a line-item bill with CPT codes, J-codes, diagnosis codes, and units billed. They must provide this within 30 days under HIPAA (45 CFR 164.524).
- Get your Explanation of Benefits (EOB): Your insurer's EOB shows what the hospital billed, what your plan's contracted rate is, what was applied to deductible, and what you owe. Compare the hospital bill to the EOB line by line.
- Look up the J-code units: Find the J-code on your bill and look up the billable unit in the CMS HCPCS database. Cross-check the units billed against your treatment notes.
- File a dispute with the hospital: Submit a written dispute to the hospital billing department identifying the specific codes, the error, and what the correct billing should be. Get a case number.
- File an insurance appeal: If the error caused your insurer to underpay or deny coverage, file a formal appeal with your plan. Plans must acknowledge appeals within 24 hours (urgent) or 72 hours (standard) and resolve them within 30 to 60 days.
- Contact your state insurance commissioner: If the insurer refuses to correct an error or denies a valid appeal, file a complaint with your state's Department of Insurance.
Documents needed:
- Itemized hospital bill with all CPT and J-codes
- Explanation of Benefits from your insurer
- Treatment notes showing drug name, dose, and administration date
- Your insurance card and policy number
- Any prior authorization documentation
Common reasons chemo billing appeals are denied:
- Missing prior authorization for the specific drug
- Out-of-network facility not disclosed before treatment
- Diagnosis code not matching the listed drug indication
- Incorrect coordination of benefits when you have secondary insurance
Medicare and Medicaid Coverage for Chemotherapy
Medicare Part B covers chemotherapy drugs administered in a doctor's office or outpatient hospital setting. Part B pays ASP + 6% for the drug and the physician fee schedule rate for administration codes. Your 20% coinsurance applies after meeting the Part B deductible ($283 in 2026).
Medicare Part D covers oral chemotherapy pills taken at home. Coverage depends on your specific plan's formulary.
Medicare supplement (Medigap) plans can cover the 20% Part B coinsurance that would otherwise be your responsibility, which matters enormously for high-cost regimens.
Medicaid covers chemotherapy for eligible low-income patients, but coverage rules vary by state. Most states cover medically necessary chemotherapy, but prior authorization requirements and covered drug lists differ. Contact your state Medicaid agency or check medicaid.gov for your state's formulary.
Manufacturer assistance programs: Most major oncology drug manufacturers offer patient assistance programs for uninsured or underinsured patients. AstraZeneca, Bristol-Myers Squibb, Pfizer, Merck, and others have programs that can provide drugs free or at reduced cost. Ask your oncology social worker or call the drug manufacturer directly.
Frequently Asked Questions
What does CPT 96413 cover exactly?
CPT 96413 covers the first hour of intravenous chemotherapy administration, including the clinical labor to start and monitor the infusion. It does not include the drug itself, IV supplies, or the facility fee. Those are billed separately.
What are J-codes on a chemotherapy bill?
J-codes are HCPCS billing codes used to identify specific injectable drugs. For chemotherapy, they run from J9000 to J9999 and specify the drug name and unit quantity. For example, J9267 is paclitaxel (1 mg per unit). The hospital multiplies the number of milligrams administered by the unit cost to calculate the drug line item.
How do I know if I was overcharged for chemo?
Request an itemized bill with all CPT and J-codes. Compare each J-code to the Medicare ASP rate published by CMS. Commercial plans pay a multiple of the Medicare rate, but the Medicare rate is the benchmark. If a line item is more than 3x to 4x the Medicare benchmark, it may signal a coding error or extreme overcharge worth challenging.
Is CPT 96417 always appropriate for combination chemo?
No. CPT 96417 is only appropriate when drugs are administered sequentially, one after the other, not simultaneously. If two drugs run concurrently through the same IV access, different billing rules apply. Billing 96417 for concurrent administration is a coding error.
Can Medicare patients be billed more than the Medicare rate?
For Medicare-assigned providers (which includes virtually all hospitals), no. The provider accepts Medicare's allowed amount as payment in full. Medicare pays 80%, and you pay 20% coinsurance. The provider cannot bill you for the difference between their chargemaster price and the Medicare rate.
What if I cannot afford my chemo bill?
Ask the hospital's financial counselor about charity care programs. Most nonprofit hospitals are required to offer financial assistance to patients below a certain income threshold (often 200% to 400% of the federal poverty level). You can also ask about interest-free payment plans, which hospitals are generally willing to offer for large balances. State pharmaceutical assistance programs and manufacturer copay cards are additional options.
How does the CoveredUSA Bill Analyzer work for chemo bills?
The CoveredUSA Bill Analyzer reads the CPT codes and J-codes on your itemized bill, looks up the current Medicare benchmark for each code, and flags line items that look inconsistent with standard billing rates. It is not a substitute for a professional billing advocate, but it gives you a fast starting point to identify which charges warrant a closer look before you pay.
What is the No Surprises Act and does it apply to chemo?
The No Surprises Act (effective 2022) protects patients from surprise out-of-network bills in emergency situations and for some scheduled services. For planned chemotherapy at an in-network facility, the Act is less directly applicable, but hospital price transparency rules under the same legislative push require facilities to publish their contracted rates for common services including infusion administration codes.
